Contact this trialFirst, we need to learn more about you.
Aromatase Inhibitor
Immunotherapy + SBRT for Metastatic Breast Cancer
Recruiting1 awardPhase 2
Pittsburgh, Pennsylvania
This trial is for women with hormone receptor and human epidermal growth factor receptor negative metastatic breast cancer. Patients will be receiving standard first line therapy and will be randomly assigned to also receive stereotactic body radiation therapy.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service